Clinical Trial Update: The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 study of albumin therapy for acute ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Albumin

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Cerebral Infarction | Phase 2 | Status: TERMINATED